van de Vijver MJ - Search Results

1

Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.

Robanus-Maandag EC, Bosch CA, Kristel PM, Hart AA, Faneyte IF, Nederlof PM, Peterse JL, van de Vijver MJ. Robanus-Maandag EC, et al. Among authors: van de vijver mj. J Pathol. 2003 Sep;201(1):75-82. doi: 10.1002/path.1385. J Pathol. 2003. PMID: 12950019

2

Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer.

Schuuring E, Verhoeven E, van Tinteren H, Peterse JL, Nunnink B, Thunnissen FB, Devilee P, Cornelisse CJ, van de Vijver MJ, Mooi WJ, et al. Schuuring E, et al. Among authors: van de vijver mj, van tinteren h. Cancer Res. 1992 Oct 1;52(19):5229-34. Cancer Res. 1992. PMID: 1394126

3

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.

van de Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio O, Nusse R. van de Vijver MJ, et al. N Engl J Med. 1988 Nov 10;319(19):1239-45. doi: 10.1056/NEJM198811103191902. N Engl J Med. 1988. PMID: 2903446

4

Immunohistochemical detection of the neu protein in tissue sections of human breast tumors with amplified neu DNA.

van de Vijver MJ, Mooi WJ, Wisman P, Peterse JL, Nusse R. van de Vijver MJ, et al. Oncogene. 1988 Feb;2(2):175-8. Oncogene. 1988. PMID: 3285295

5

Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene.

van de Vijver M, van de Bersselaar R, Devilee P, Cornelisse C, Peterse J, Nusse R. van de Vijver M, et al. Mol Cell Biol. 1987 May;7(5):2019-23. doi: 10.1128/mcb.7.5.2019-2023.1987. Mol Cell Biol. 1987. PMID: 3299059 Free PMC article.

6

Amplification and over-expression of the neu oncogene in human breast carcinomas.

van de Vijver MJ, Mooi WJ, Peterse JL, Nusse R. van de Vijver MJ, et al. Eur J Surg Oncol. 1988 Apr;14(2):111-4. Eur J Surg Oncol. 1988. PMID: 3360152

7

Ductal carcinoma in situ: a proposal for a new classification.

Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, van de Vijver MJ, Zafrani B. Holland R, et al. Among authors: van de vijver mj. Semin Diagn Pathol. 1994 Aug;11(3):167-80. Semin Diagn Pathol. 1994. PMID: 7831528 Review.

8

Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.

Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P. Cornelis RS, et al. Among authors: van de vijver mj, van vliet m. Cancer Res. 1994 Aug 1;54(15):4200-6. Cancer Res. 1994. PMID: 8033152

9

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.

Vos CB, Cleton-Jansen AM, Berx G, de Leeuw WJ, ter Haar NT, van Roy F, Cornelisse CJ, Peterse JL, van de Vijver MJ. Vos CB, et al. Among authors: van roy f, de leeuw wj, van de vijver mj. Br J Cancer. 1997;76(9):1131-3. doi: 10.1038/bjc.1997.523. Br J Cancer. 1997. PMID: 9365159 Free PMC article.

10

Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.

De Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S, Van Roy F, Cornelisse CJ, Cleton-Jansen AM. De Leeuw WJ, et al. Among authors: van roy f, van de vijver mj. J Pathol. 1997 Dec;183(4):404-11. doi: 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9. J Pathol. 1997. PMID: 9496256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters